ascopubs.org

PI3K/AKT pathway biomarkers analysis from the phase III IPATential150 trial of ipatasertib plus abiraterone in metastatic castration-resistant prostate cancer.

CheckMate 9KD Arm B final analysis: Efficacy and safety of nivolumab plus docetaxel for chemotherapy-naïve metastatic castration-resistant prostate cancer. Genomic landscape of advanced prostate ...
ascopubs.org

Final analysis of the randomized phase 3 ESCORT-1st trial: Camrelizumab plus chemotherapy as first-line treatment for advanced or metastatic esophageal squamous cell carcinoma.

Leveraging cfDNA fragmentomic features in a stacked ensemble model for early detection of esophageal squamous cell carcinoma. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This ...
The New England Journal of Medicine

A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy

IgA nephropathy, the most common primary glomerulopathy worldwide, is a kidney disorder of B-cell origin characterized by mesangial accumulation of IgA-containing immune complexes. In at least 50% of ...
iaea.org

Analysis Phase of Systematic Approach to Training (SAT) for Nuclear Plant Personnel

The intention of this publication is to provide Member States with examples of the analysis phase to form the foundation of SAT-based training programmes. Although methods of analysis vary, the ...